Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

被引：0
作者：
Mazeron, MC [1 ]
Fillet, AM
Salmon, D
Boukli, N
Houhou, N
Sénéchal, B
Matheron, S
Gozlan, J
Leport, C
Katlama, C
Scieux, C
Imbert, BM
Deny, P
Bour, JB
Freymuth, F
Chanzy, B
Chaput, S
Costagliola, D
机构：
[1] Hop Lariboisiere, Dept Virol, F-75475 Paris, France
[2] Hop La Pitie Salpetriere, CERVI, Dept Virol, Paris, France
[3] Hop St Antoine, Dept Virol, F-75571 Paris, France
[4] Hop Bichat Claude Bernard, Dept Virol, F-75877 Paris, France
[5] Hop St Louis, Dept Virol, Paris, France
[6] Hop Hotel Dieu, Dept Virol, Nantes, France
[7] Hop Avicenne, Dept Virol, F-93009 Bobigny, France
[8] Hop Boccage, Dept Virol, Dijon, France
[9] Hop G Clemenceau, Dept Virol, Caen, France
[10] Hop Michallon, Dept Virol, Grenoble, France
[11] Hop Cochin, Dept Med, F-75674 Paris, France
[12] Hop Bichat Claude Bernard, Dept Infect Dis, F-75877 Paris, France
[13] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[14] INSERM, EMI 0214, Dept Biostat, Paris, France
来源：
AIDS | 2003年 / 17卷 / 05期
关键词：
D O I：
10.1097/00002030-200303280-00029
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：784 / 786
页数：3
相关论文
共 50 条
[31]   Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients [J].
Sendi, PP ;
Bucher, HC ;
Harr, T ;
Craig, BA ;
Schwietert, M ;
Pfluger, D ;
Gafni, A ;
Battegay, M .
AIDS, 1999, 13 (09) :1115-1122
[32]   Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients [J].
Barbaro, G ;
Klatt, EC .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) :1475-1481
[33]   Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy [J].
Takarabe, Daisuke ;
Rokukawa, Yuka ;
Takahashi, Yoshihiko ;
Goto, Atsushi ;
Takaichi, Maki ;
Okamoto, Masahide ;
Tsujimoto, Tetsuro ;
Noto, Hiroshi ;
Kishimoto, Miyako ;
Kaburagi, Yasushi ;
Yasuda, Kazuki ;
Yamamoto-Honda, Ritsuko ;
Tsukada, Kunihisa ;
Honda, Miwako ;
Teruya, Katsuji ;
Kajio, Hiroshi ;
Kikuchi, Yoshimi ;
Oka, Shinichi ;
Noda, Mitsuhiko .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08) :4056-4060
[34]   Dyspepsia in HIV-infected patients under highly active antiretroviral therapy [J].
Werneck-Silva, Ana Luiza ;
Prado, Ivete Bedin .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) :1712-1716
[35]   Valuation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy [J].
Fantoni, M ;
Del Borgo, C ;
Autore, C .
AIDS, 2003, 17 :S162-S169
[36]   Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy [J].
Abzug, Mark J. ;
Song, Lin-Ye ;
Fenton, Terence ;
Nachman, Sharon A. ;
Levin, Myron J. ;
Rosenblatt, Howard M. ;
Pelton, Stephen I. ;
Borkowsky, William ;
Edwards, Kathryn M. ;
Peters, Jody .
PEDIATRICS, 2007, 120 (05) :E1190-E1202
[37]   Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy [J].
Soriano, V ;
Dona, C ;
Rodríguez-Rosado, R ;
Barreiro, P ;
González-Lahoz, J .
AIDS, 2000, 14 (04) :383-386
[38]   Prevalence and Risk Factors of Metabolic Syndrome in HIV-Infected Patients Receiving the Highly Active Antiretroviral Therapy [J].
Pongthananikorn, Suyanee ;
Jantarathaneewat, Kittiya ;
Somnikha, Pondsarun ;
Jaturapullarp, Sirirat ;
Meksawan, Kulwara .
TOPICS IN CLINICAL NUTRITION, 2018, 33 (01) :41-49
[39]   Personality changes in HIV-infected patients who have been receiving highly active antiretroviral therapy [J].
Dobrakowski, Pawel P. ;
Skalski, Sebastian .
HIV & AIDS REVIEW, 2019, 18 (03) :165-175
[40]   Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy [J].
Nlend, A. E. Njom ;
Loussikila, A. B. .
MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (01) :32-37
12345